Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Go back to Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update| (NASDAQ: KNSA) | Delayed: 77.32 -0.76 (0.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $78.08 | 52 Week High | $ | |||
| Open | $78.00 | 52 Week Low | $ | |||
| Day High | $78.12 | P/E | N/A | |||
| Day Low | $76.65 | EPS | $ | |||
| Volume | 50,378 | |||||

